Patents by Inventor Angela J. Henderson

Angela J. Henderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MYELOID DERIVED SUPPRESSOR CELL INHIBITING AGENTS
    Publication number: 20160287686
    Abstract: Myeloid derived suppressor cell (MDSC) inhibitory agents and vaccine and/or adjuvant enhancers are provided. Improved vaccine treatment regimens employing these agents are also provided. Cancer vaccines and methods for inhibiting tumor growth and cancer metastases are also presented. The myeloid derived suppressor cell (MDSC) inhibiting agents are described as bisphosphonates (such as liposomal clodronate) and CCR2 inhibitors and/or CCR2 antagonists. Methods for enhancing antibody titer levels in response to an antigen of interest are also provided.
    Type: Application
    Filed: March 17, 2016
    Publication date: October 6, 2016
    Inventors: Steven W. Dow, Angela J. Henderson, Leah Mitchell
  • Myeloid derived suppressor cell inhibiting agents
    Patent number: 9320735
    Abstract: Myeloid derived suppressor cell (MDSC) inhibitory agents and vaccine and/or adjuvant enhancers are provided. Improved vaccine treatment regimens employing these agents are also provided. Cancer vaccines and methods for inhibiting tumor growth and cancer metastases are also presented. The myeloid derived suppressor cell (MDSC) inhibiting agents are described as bisphosphonates (such as liposomal clodronate) and CCR2 inhibitors and/or CCR2 antagonists. Methods for enhancing antibody titer levels in response to an antigen of interest are also provided.
    Type: Grant
    Filed: June 22, 2011
    Date of Patent: April 26, 2016
    Assignee: Colorado State University Research Foundation
    Inventors: Steven W. Dow, Angela J Henderson, Leah Mitchell
  • MYELOID DERIVED SUPPRESSOR CELL INHIBITING AGENTS
    Publication number: 20120156280
    Abstract: Myeloid derived suppressor cell (MDSC) inhibitory agents and vaccine and/or adjuvant enhancers are provided. Improved vaccine treatment regimens employing these agents are also provided. Cancer vaccines and methods for inhibiting tumor growth and cancer metastases are also presented. The myeloid derived suppressor cell (MDSC) inhibiting agents are described as bisphosphonates (such as liposomal clodronate) and CCR2 inhibitors and/or CCR2 antagonists. Methods for enhancing antibody titer levels in response to an antigen of interest are also provided.
    Type: Application
    Filed: June 22, 2011
    Publication date: June 21, 2012
    Applicant: Colorado State University Research Foundation
    Inventors: Steven W. Dow, Angela J. Henderson, Leah Mitchell